MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tremors: Treatment"

  • 2018 International Congress

    Change of tremor dominant body side after deep brain stimulation in patients with Parkinson’s disease

    P. Wouters, M. Janssen, P. Kubben, L. Ackermans, Y. Temel, M. Kuijf (Maastricht, Netherlands)

    Objective: In this study, we aimed to determine changes in distribution of tremor dominant body side after DBS and searched for possible explanations if tremor…
  • 2018 International Congress

    Distance to white matter tracts predicts STN deep brain stimulation outcome of tremor and dysarthria in Parkinson’s disease

    L. Boon, N. Prent, W. Potters, M. Caan, H. Berendse, R. de Bie, P. vd Munckhof, P. Schuurman, A. van Rootselaar (Amsterdam, Netherlands)

    Objective: To establish the association between the distance of subthalamic nucleus (STN) deep brain stimulation (DBS) electrode contact points to relevant white matter tracts and…
  • 2018 International Congress

    Phase-locked transcranial alternating current stimulation of the cerebellum for essential tremor

    S. Schreglmann, D. Wang, E. Boyden, K. Bhatia, J. Rothwell, N. Grossman (London, United Kingdom)

    Objective: To test whether hand tremor can be mitigated by delivering an electrical stimulation to the ipsilateral cerebellum, phase-locked to the tremulous hand movement. Background:…
  • 2018 International Congress

    Staged bilateral Gamma Knife Thalamotomy for severe essential tremor

    T. Witjas-Slucki, R. Carron, JP. Azulay, A. Eusebio, J. Regis (Marseille, France)

    Objective: To assess the feasibility and tolerance of staged bilateral Gamma Knife thalamotomy (GKT) for Essential Tremor (ET) Background: Unilateral GKT is an established treatment…
  • 2017 International Congress

    TETRAS applicability and study design in randomized, placebo controlled clinical trial of Cav3 modulation for essential tremor patients.

    Y. Maricich, E. Newbold, R. Elble (Charlottesville, VA, USA)

    Objective: We will study CX-8998, a selective Cav3 antagonist with safety data in 194 patients,  in the treatment of ET. Few large controlled ET trials…
  • 2017 International Congress

    Comparison of the effect of thalamic DBS/coagulation on tremor and thalamic neuronal activity in spinocerebellar ataxia and essential tremor

    T. Hashimoto, A. Muralidharan, K. Yoshida, T. Goto, T. Yako, K. Baker, J. Vitek (Matsumoto, Japan)

    Objective: To investigate the effects of deep brain stimulation (DBS) or lesions of the ventral intermediate nucleus (Vim) of the thalamus for spinocerebellar ataxia (SCA)…
  • 2017 International Congress

    Efficacy and safety of incobotulinumtoxinA (inco/A) for essential tremor using kinematics-guided clinical decision support: A randomized, double-blind, placebo-controlled trial

    M. Jog, J. Lee, M. Althaus, A. Scheschonka, H. Dersch, E.T. Study Team, D. Simpson (London, ON, Canada)

    Objective: To demonstrate improvement of arm tremor severity and hand function with kinematics-guided inco/A therapy Background: Botulinum neurotoxin A (BoNT-A) therapy of debilitating tremor symptoms…
  • 2017 International Congress

    Open label study of cannabidiol in Parkinson disease

    M. Leehey, Y. LIU, C. EPSTEIN, F. HART, J. BAINBRIDGE, M. COOK, S. SILLAU, Z. BAUD, H. NEWMAN (AURORA, CO, USA)

    Objective: To determine if cannabidiol (CBD) is tolerated and effective in Parkinson disease (PD) and the dosage needed for a Phase 2 randomized controlled trial.…
  • 2017 International Congress

    The occurrence of dopamine-responsive and dopamine-resistant resting tremor in Parkinson’s disease

    H. Zach, M. Dirkx, D. Roth, j. Pasman, B. Bloem, R. Helmich (Nijmegen, Netherlands)

    Objective: To investigate dopamine-responsiveness of resting tremor in Parkinson’s disease Background: Unlike the core Parkinson motor symptom, bradykinesia, resting tremor has a variable response to…
  • 2017 International Congress

    Effect of deep brain stimulation of the subthalamic nucleus on cranial tremor in Parkinson’s disease

    L. Cameron, C. Kilbane, A. Shaikh (Cleveland, OH, USA)

    Objective: To analyze the effect of deep brain stimulation (DBS) of the subthalamic nucleus (STN) on cranial tremor in Parkinson’s disease (PD). Background: STN DBS…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 17
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley